1) and Drug Interactions (7)]. The risk of hypoglycemia can be reduced by a discount during the dose of sulfonylurea (or other concomitantly administered insulin secretagogue) or insulin. Inform individuals employing these concomitant medicines of the potential risk of hypoglycemia and teach them to the signs and signs of hypoglycemia.Assuming the